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Abstract 
Regression Modeling for Competing Risks Based on Pseudo-Observations, with 
Application to Breast Cancer Study  
Shangzhen Chen, MS 
University of Pittsburgh, 2019 
Abstract 
In medical research, a patient might experience a failure due to different causes, where 
each cause would be considered a competing risk. The standard method to analyze the type of data 
that is used most frequently in medical research is the cause-specific hazard regression analysis 
based on the Cox proportional hazards model or the cumulative incidence function-based method. 
The Cox proportional hazards model is used to model the cause-specific event rates and treat the 
other type of events as independent censoring. The new methods which have been proposed 
directly assess the effect of covariates on the cumulative incidence functions, which is the 
pseudo-observations approach proposed by Andersen and Klein in 2007. The scheme 
of pseudo-observations approach is to (1) choose some fixed time points that are equally spaced 
on the event scale, (2) calculate pseudo-observations for each individual at those fixed time 
points using the jackknife technique, and (3) fit a generalized linear model with GEE 
method based on the conditional cumulative incidence function using the pseudo-observations. 
We applied the pseudo-observation approach to a breast cancer study. The goal of the study 
was to assess the effect of the covariates on the cumulative incidence function. The results showed 
that nodal status and tumor size are positively related to cumulative incidence of death following 
breast cancer recurrence and that age has a negative relationship with the cumulative incidence of 
death following breast cancer recurrence. In addition, nodal status and tumor size are not 
v 
significantly associated with death due to causes other than breast cancer. Age is positively related 
to death not due to breast cancer.  
Public health significance: Because the method explored and applied here is a readily 
accessible procedure for censored time-to-event data, providing straightforward interpretation of 
the effect of the predictors on the cumulative incidence function, dissemination of the method 
through a real world example would help the researchers, stakeholders, and patients in public 
health understand the usefulness of the method and grasp the interpretation of the analysis for 
competing risks data. 
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1.0 Introduction 
Survival data measure the time from a reference time point to an event time point [14]. If 
there are no incomplete observations in survival data, the standard methods for the continuous 
outcome or binary outcome can be used for analysis [2].  However, since survival data is often 
subject to right censoring, where the subject leaves the cohort before experiencing the event, 
survival methods must account for censoring through parametric or non-parametric estimation, or 
inference, either through unadjusted survival distributions or multivariate regression analysis [2].  
For censored survival data, one way of adopting the standard method is to replace a 
summary measure of interest as a function of time, say f(x), by their pseudo-observations [2]. The 
estimator 𝜃𝜃� is the expected value of f(x) exists no matter whether the data are complete or not [2]. 
If the data are complete, the expected value can be estimated by  ∑ 𝑓𝑓(𝑥𝑥𝑖𝑖)𝑖𝑖
𝑛𝑛
. If the data are not 
complete, an estimate of the expected value is also available such as Kaplan-Meier estimator for 
survival function [2]. The pseudo-observation is defined as θ�i = nθ� − (n − 1)θ�−i, i = 1, …, n, 
where  θ�−i is an estimator based on sample size of (n-1) after the ith observation is deleted from 
the data set. The pseudo-observation θ�i is used for all individuals not only for the unobserved 
individuals (censored objects) [2]. 
Pseudo-observations can be applied to several areas in survival analysis such as the survival 
function, the restricted mean survival time and transition or state occupation probabilities in multi-
state models [2]. Competing risks model is a special case of multi-state models. It only has an 
initial state and some exclusive causes of final state, whereas multi-state model is the model which 
2 
not only contains initial state and final states but also has intermediate events [8]. In this current 
work, we apply the pseudo observation method to competing risks regression.  
Competing risks happen when the event of interest is not observed due to another type of 
event that precedes it. For example, in a cancer study, researchers want to investigate the time from 
the beginning of a treatment to tumor-related death. In this situation, the patients that die due to 
the other causes become competing events. There are several ways of analyzing survival data with 
competing risks such as cause-specific hazard regression, subdistribution hazard regression, 
mixture models, vertical modelling and regression modeling of the competing risks data based on 
pseudo-observations [8]. This thesis focuses on regression modeling of the competing risks data 
based on pseudo-observations. Competing risks probabilities can be summarized by the 
cumulative incidence function [11]. This function defines the cumulative probability of subject 
who fail from the cause j.   
𝐶𝐶𝑗𝑗(t) = Pr[𝑇𝑇 ≤ 𝑡𝑡, 𝜖𝜖 = 𝑗𝑗] =  ∫ ℎ𝑗𝑗(𝑢𝑢)𝑆𝑆(𝑢𝑢−)𝑑𝑑𝑢𝑢𝑡𝑡0     (1) 
Where 𝑆𝑆(𝑢𝑢 −) = 𝑃𝑃(𝑇𝑇 ≥ 𝑢𝑢) and ℎ𝑗𝑗(𝑢𝑢) =  lim
∆𝑢𝑢→0
1
∆𝑢𝑢
𝑃𝑃(𝑢𝑢 ≤ 𝑇𝑇 < 𝑢𝑢 + ∆𝑢𝑢, 𝜖𝜖 = 𝑗𝑗|𝑇𝑇 ≥ 𝑢𝑢) 
In this thesis, we formulate a regression model of breast cancer data based on pseudo 
observations. Breast cancer is the most common cancer in women [9]. About one in eight to ten 
women will get breast cancer in their lifetime [9]. There are five stages of breast cancer, and 
doctors use TNM system to describe the stages. TNM represents Tumor (T), Node (N), and 
Metastasis (M), where tumor means the size and location of a tumor [6]. Tumor size can help 
doctors figure out the prognosis such as the likely outcome of the disease, decide the best treatment 
option, and determine whether a certain clinical trial may fit for the patient. Node means whether 
the tumor spread to the lymph nodes [6]. There are two lymph node status; negative and positive. 
Lymph node-negative means that the tumor does not spread to axillary lymph nodes [12]. Lymph 
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node-positive means that the axillary lymph nodes contain the cancer [12]. Lymph node status is 
also a reference for doctors to determine the effect of the prognosis [12]. The prognosis is better if 
the tumor does not spread to the lymph nodes. Metastasis means that the cancer has spread to the 
other part of body. Stage 0 describes disease where the tumor has not spread to the surrounding 
tissue of the breast. In stage 4, the tumor has spread to the other organs. There are several ways to 
treat breast cancer. Stage 0 is the least severe status of breast cancer, and stage 4 is the most severe 
status of breast cancer. The treatment that doctor chooses depends on the types of breast cancer 
and how far it has spread. People with breast cancer often get a combination of treatments. The 
treatments include surgery, chemotherapy, hormonal therapy, biological therapy and radiation 
therapy. The patients in the study we are analyzing in this thesis were treated with surgery and 
radiation therapy.    
Data for this study were taken from the B-04 phase III randomized clinical trial conducted 
by the National Surgical Adjuvant Breast and Bowel Project (NSABP). Participants were 
randomized to one of two types of surgical treatments. One was traditional radical mastectomy; 
the other was less aggressive total mastectomy. Traditional radical mastectomy is also called 
Halsted mastectomy, which is no longer a common procedure unless patients have severe breast 
cancer which has invaded muscle under the breast tissue. A radical mastectomy removes all of the 
breast tissue with the tumor and removes all of the lymph nodes under the arm and muscle which 
lies under the breast, whereas total mastectomy only removes the breast tissue with the tumor [16]. 
The B-04 study compared the two treatments on survival of patients. The women were separated 
into two groups. The women in the first group were with negative axillary nodes, and the women 
in the second group were with positive axillary nodes. The patients in one of groups were treated 
with traditional radical mastectomy or less aggressive total mastectomy randomly [4]. The study 
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lasted 30 years, and about 30% of patients with negative node and 20% of patients with positive 
node were censored. Patients could be censored, died following breast cancer recurrence, or died 
due to other reasons. The study showed that the less aggressive mastectomy is better than the 
traditional aggressive surgery [4]. 
In this thesis, we will formulate generalized linear model with GEE based on pseudo-
observations to assess the effect of covariates on cumulative incidence function. In the method 
section, we will explain the concepts and the procedure of regression modeling of competing risks 
based on pseudo-observations in detail. In the result section, we will apply the pseudo-observations 
method to NSABP B-04 study and find the relationship between the cumulative incidence and the 
covariates.    
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2.0 Methodology 
In this section, we present an approach to formulate a regression model based on the 
cumulative incidence function. The reasons why we apply pseudo-observations methods to 
cumulative incidence function are that (1) the pseudo-observations method for censored survival 
data makes the regression modeling more flexible, allowing for using different link functions, (2) 
people can use the standard generalized linear model to estimate the parameters and get the 
relationship between covariates and cumulative incidence directly, (3) compared to cause-specific 
hazard regression or subdistribution hazard regression analysis, the generalized linear model with 
GEE based on the pseudo-observations does not require strict assumption such as the proportional 
hazard assumption.    
2.1 Cumulative Incidence Function 
The cumulative incidence function is defined as the probability of a particular event which 
is due to cause j occurring before a given time [10]. The cumulative incidence function is a 
nondecreasing function of time with 𝐶𝐶𝑗𝑗(∞) = Pr [𝜀𝜀 = 𝑗𝑗]. [10] The estimated cumulative incidence 
function for cause j is [2,10]:  
?̂?𝐶𝑗𝑗(t) = Pr[𝑇𝑇 ≤ 𝑡𝑡, 𝜖𝜖 = 𝑗𝑗] =  ∫ ?̂?𝑆(𝑢𝑢 −)𝑑𝑑𝑡𝑡0 𝐴𝐴𝚥𝚥� (𝑢𝑢) =  ∫ ∏ (1 − ∑ 𝑑𝑑𝑁𝑁ℎ(𝑇𝑇𝑖𝑖)𝐾𝐾ℎ=1𝑌𝑌(𝑇𝑇𝑖𝑖) ) 𝑑𝑑𝑁𝑁𝑗𝑗(𝑢𝑢)𝑌𝑌(𝑢𝑢)𝑇𝑇𝑖𝑖<𝑢𝑢𝑡𝑡0         (2)
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In this formula, 𝐴𝐴𝚥𝚥� (𝑢𝑢) =  ∫ 𝑑𝑑𝑁𝑁𝑗𝑗(𝑢𝑢)𝑌𝑌(𝑢𝑢)𝑡𝑡0  is the Nelson-Aalen estimator for the cumulative cause-
specific hazard Aj(t) for cause j failure. Nj(u) is a counting process Nj(t) = ∑ 𝐼𝐼�𝑋𝑋�𝑖𝑖 ≤ 𝑇𝑇,𝐷𝐷𝑖𝑖 = 𝑗𝑗�,𝑖𝑖
𝑗𝑗 = 1, 2 , where 𝑋𝑋�𝑖𝑖  is the right censored or failure time and 𝐷𝐷𝑖𝑖  is the event the individual 
experiences. ∏ (1 − ∑ 𝑑𝑑𝑁𝑁ℎ(𝑇𝑇𝑖𝑖)𝐾𝐾ℎ=1
𝑌𝑌(𝑇𝑇𝑖𝑖) )𝑇𝑇𝑖𝑖<𝑢𝑢  is the Kaplan-Meier estimate before time u.  
The formula can also be written as [9]: 
?̂?𝐶𝑗𝑗(t) =   ∑ 𝑑𝑑ℎ𝑘𝑘𝑌𝑌ℎ𝑡𝑡ℎ≤𝑡𝑡 ∏ �𝑌𝑌𝑖𝑖−(𝑑𝑑1𝑖𝑖+𝑑𝑑2𝑖𝑖)𝑌𝑌𝑖𝑖 � , 𝑖𝑖 = 1, . .  . ,𝑛𝑛,   𝑗𝑗 = 1,  2,    ℎ = 1, … ,𝑀𝑀  𝑡𝑡𝑖𝑖<𝑡𝑡ℎ     (3) 
Where 𝑡𝑡ℎis the fixed time points which people choose, 𝑡𝑡𝑖𝑖 is the time where one of events 
happens, Yh is the number at risk at time th, d1h and d2h are the number of type 1 and type 2 
events at time th, and ∏ �𝑌𝑌𝑖𝑖−(𝑑𝑑1𝑖𝑖+𝑑𝑑2𝑖𝑖)
𝑌𝑌𝑖𝑖
�𝑡𝑡𝑖𝑖<𝑡𝑡ℎ    is the Kaplan Meier estimator of the survival 
function. 
2.2 Jack-knife statistic and Pseudo-Observations 
The pseudo-observations are from a jackknife technique [3]. The Jackknife procedure is a 
method of resampling [12]. Each jackknife sample is selected from the original data and deleted 
one observation from the set [12]. So, the ith Jackknife sample vector is like:  
𝑿𝑿[𝑖𝑖] = {𝑋𝑋1,𝑋𝑋2, … ,𝑋𝑋𝑖𝑖−1,𝑋𝑋𝑖𝑖+1, … ,𝑋𝑋𝑛𝑛−1,𝑋𝑋𝑛𝑛}. 
The Jackknife procedure can be used to generate the “pseudo-values”. The pseudo values 
are treated as the independent random variables. The ith pseudo-values are defined as: 
𝜃𝜃�𝑖𝑖 = 𝑛𝑛𝜃𝜃� − (𝑛𝑛 − 1)𝜃𝜃�−𝑖𝑖.                                                                    (4) 
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where θ = E[f(X)], 𝜃𝜃� is an unbiased estimator (or approximately unbiased) estimator of θ, 
and 𝜃𝜃�−𝑖𝑖 is the estimator whose sample size is n-1 due to eliminating the ith observation from the 
data. A Jackknife pseudo value can be viewed as a biased-corrected estimator, which correct the 
bias 𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏�𝑗𝑗𝑗𝑗𝑗𝑗𝑗𝑗 = (n − 1)(𝜃𝜃�−𝑖𝑖 − 𝜃𝜃�) [13]. 
The pseudo observations applied in competing risks in this thesis are from the cumulative 
incidence function, implying that our f(X) will be the cumulative incidence function. For fixed 
time points (τ1, τ2, τ3, …, τM), there will be M cumulative incidence estimates for each observation. 
The estimated cumulative incidence function at each time point is calculated based on cumulative 
incidence function ?̂?𝐶𝑗𝑗(𝜏𝜏ℎ)  which is derived from the complete data set and the cumulative 
incidence function  ?̂?𝐶𝑗𝑗
(𝑖𝑖)(𝜏𝜏ℎ) which is derived from sample size n-1 [10]. The pseudo-values for
the ith observation at time 𝜏𝜏ℎ is defined as: 
𝜃𝜃�𝑖𝑖ℎ = 𝑛𝑛?̂?𝐶𝑗𝑗(𝜏𝜏ℎ) − (𝑛𝑛 − 1)?̂?𝐶𝑗𝑗(𝑖𝑖)(𝜏𝜏ℎ), 𝑖𝑖 = 1, … ,𝑛𝑛,   𝑗𝑗 = 1, … ,𝑘𝑘,ℎ = 1, … ,𝑀𝑀.           (5)
where i represents observations, j represents causes, and h represents time points. 
If there is no censoring, there are 𝑛𝑛?̂?𝐶𝑗𝑗(𝜏𝜏ℎ) events of type j occurring up to time t, and 𝜃𝜃�𝑖𝑖’s 
are independent. When there is censoring, 𝜃𝜃�𝑖𝑖’s are close to the number of the type j events and are 
approximately independent [11]. Because the pseudo values are independent between different 
individuals, we can use the results of generalized linear model to model the effects of covariates 
on the outcomes (cumulative incidence function) [11]. 
2.3 Generalized Linear Model with Generalized estimating Equation (GEE) 
We assume a generalized linear model 
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g(𝜃𝜃𝑖𝑖ℎ) =  𝛼𝛼ℎ +  𝛾𝛾𝑇𝑇𝑍𝑍𝑖𝑖ℎ =  𝛽𝛽𝑇𝑇𝑍𝑍𝑖𝑖ℎ, 𝑖𝑖 =  1, … ,𝑛𝑛,ℎ =  1, … ,𝑀𝑀. 
where g(.) is the link function.  𝜃𝜃𝑖𝑖ℎ is the pseudo-observations. 𝛼𝛼ℎ is the intercept when 
covariates are equal to zero. 𝑍𝑍𝑖𝑖ℎrepresent covariates.  
Two link functions for the cumulative incidence are considered for this model. One is 
complementary log-log function on 1-x, i.e. g(𝑥𝑥) =  log (−log (1 − 𝑥𝑥))  and the other is logit 
function on x, i.e. g(𝑥𝑥) = log 𝑥𝑥
1−𝑥𝑥
. When the complementary log-log link function is applied to the 
survival function, it mimics the proportional hazard on the subdistribution hazards function [7]. 
The regression model with the cumulative incidence function for logistic link function for 
specific cause j is  
logit �𝐶𝐶𝑖𝑖𝑗𝑗(𝑡𝑡ℎ|𝑍𝑍)� = log � 𝐶𝐶𝑖𝑖𝑗𝑗(𝑡𝑡ℎ|𝑍𝑍)1−𝐶𝐶𝑖𝑖𝑗𝑗(𝑡𝑡ℎ|𝑍𝑍)� =  𝛽𝛽𝑇𝑇𝑍𝑍𝑖𝑖𝑗𝑗ℎ, 𝑖𝑖 =  1, … ,𝑛𝑛,ℎ =  1, … ,𝑀𝑀.              (6) 
The regression model with the cumulative incidence function for complementary log-log 
link function for specific cause j is   log �− log �1 −  𝐶𝐶𝑖𝑖𝑗𝑗(𝑡𝑡ℎ|Z)�� =  𝛽𝛽𝑇𝑇𝑍𝑍𝑖𝑖𝑗𝑗ℎ, 𝑖𝑖 =  1, … ,𝑛𝑛,ℎ =  1, … ,𝑀𝑀.                             (7) 
Since the pseudo observations at different time points (for an individual) are correlated, we 
use the generalized estimating equation (GEE) method to estimate the regression parameters β and 
variance. The GEE approach, as introduced by Liang and Zeger (1986), models the marginal mean 
structure. To solve the estimated β, we need to solve the equation 
U(β) =  ∑ 𝑈𝑈𝑖𝑖(𝛽𝛽)𝑖𝑖  = ∑ � 𝑑𝑑𝑑𝑑𝑑𝑑 𝑔𝑔−1(𝛽𝛽𝑇𝑇𝑍𝑍𝑖𝑖ℎ)�𝑇𝑇 𝑉𝑉𝑖𝑖−1(𝛽𝛽)(𝜃𝜃�𝑖𝑖 − 𝑔𝑔−1(𝛽𝛽𝑇𝑇𝑍𝑍𝑖𝑖ℎ))𝑖𝑖  = 0     (8) 
where 𝑔𝑔−1(𝛽𝛽𝑇𝑇𝑍𝑍𝑖𝑖ℎ) =  𝜃𝜃𝑖𝑖ℎ, and 𝑉𝑉𝑖𝑖(𝛽𝛽) is the working covariance matrix. 
To estimate the variance of ?̂?𝛽, a sandwich estimator is calculated as  
𝑣𝑣𝑏𝑏𝑣𝑣� �?̂?𝛽� = 𝐼𝐼�?̂?𝛽�−1𝑣𝑣𝑏𝑏𝑣𝑣� (𝑈𝑈(𝛽𝛽))(𝐼𝐼(?̂?𝛽)−1).
where 
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I(β) =  ∑ �𝑑𝑑𝑔𝑔−1�𝑑𝑑𝑇𝑇𝑍𝑍𝑖𝑖�
𝑑𝑑𝑑𝑑
�
𝑇𝑇
𝑉𝑉𝑖𝑖
−1
𝑖𝑖 (𝑑𝑑𝑔𝑔−1(𝑑𝑑𝑇𝑇𝑍𝑍𝑖𝑖)𝑑𝑑𝑑𝑑 ), and 
𝑣𝑣𝑏𝑏𝑣𝑣� �𝑈𝑈(𝛽𝛽)� =  ∑ 𝑈𝑈𝑖𝑖�?̂?𝛽�𝑇𝑇𝑈𝑈𝑖𝑖(?̂?𝛽)𝑖𝑖 .
In summary, we presented an approach to formulate a regression model based on the 
cumulative incidence function. Suppose we have data with n individuals, and each observation 
consists of four components; observation time (Ti), censoring indicator (δi), type of event (εi) and 
covariates (Xi). To formulate a regression model, first we choose the number of time points 
which are equally spaced on event scale, second we calculate two kinds of cumulative incidence 
function of the survival data base on full data and “leave-one-out” data, third we create the 
pseudo observations, and finally we apply the generalized linear model with GEE based on the 
pseudo-observations. 
10 
3.0 Result 
3.1 Bone Marrow Transplant study 
First, we reproduced the analysis results of Bone Marrow Transplant Study to verify our 
codes that will be used to analyze NSABP B-04 study. Andersen and Klein (2007) applied the 
pseudo-observations method in survival analysis. They formulated regression models for 
parameters like the survival function, the restricted mean survival time, and the cumulative 
incidence function. In this thesis, we focus on regression modeling for competing risk data based 
on pseudo observation methods. Andersen and Klein (2007) applied the method on bone marrow 
transplant data which was in the R package KMsurv. The data set contained 137 observations. 
They focused on investigating the cumulative incidence of relapse. They fit a generalized linear 
model with the GEE method based on the pseudo values of the cumulative incidence of relapse. 
They chose the model with complementary log-log link and independent working covariance. 
Complementary log-log transformation was applied to pseudo values, and types of disease, age, 
types of French-American-British (FAB) which is a classification system of acute myeloblastic 
leukemia (AML) and different time points as covariates. We obtained the same results as in 
Andersen and Klein (2007), which was shown in the Table 1. 
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Table 1 Complementary Log-Log Model for Relapse 
Relapse  
Link Function = complementary log-log 
Variable  Mean SD Z p-value 
Time Points 50 -3.55 0.85 -4.17 <0.001 
 105 -2.54 0.67 -3.76 0.0002 
 170 -2.07 0.66 -3.14 0.002 
 280 -1.73 0.64 -2.68 0.007 
 530 -1.43 0.63 -2.27 0.02 
AML Low Risk  -1.77 0.67 -2.62 0.0089 
AML High Risk  -0.24 0.59 -0.41 0.68 
FAB  1.13 0.53 2.16 0.031 
Age  0.01 0.02 0.63 0.53 
3.2 NSABP B-04 Study 
The NSABP B-04 study contained 1,599 patients, with data on patient ID, survival time, 
type of event, nodal status, age and tumor size, etc. 48% of the entire patients died following breast 
cancer recurrence (type 1), 30% died for reasons unrelated to breast cancer (type 2), and 23% were 
censored. 1038 (65%) patients in lymph-node negative status (nodal status 0) and 561 (35%) 
patients in lymph-node positive status (nodal status 1). Figure 1 shows a greater cumulative 
incidence for death following breast cancer recurrence versus death unrelated to breast cancer. 
 
 12 
 
Figure 1 Cumulative Incidence Curve of type 1 and type 2 events 
 
First, we estimated the effects of the covariates in the Cox model on the cause-specific 
hazard function and checked whether the Cox model fit the proportional hazards assumption. The 
Cox model for the cause-specific hazard function is the common model used to examine the effects 
of covariates on specific cause of failure. For the type 1 events, the p-values from the Cox 
proportional hazards model in Table 2 show that nodal status and tumor size are positively 
associated with death following breast cancer recurrence. In Table 3, the p-values indicate 
nonproportional hazards in all the covariates and hence globally, and Figure 2 also indicates that 
the log-hazard ratio changes over time. The Cox proportional hazards model for type 1 events 
violates the proportionality assumptions. In general, there are two ways to accommodate the non-
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proportional hazards. One is to generate the stratified proportional hazards model; the other is to 
fit a model with time-dependent covariates using interaction terms. For type 2 events, the p-values 
of Cox proportional hazards model in Table 4 show that the hazard rate of death not due to breast 
cancer is higher when the patients are older. The Cox proportional hazards model for type 2 events 
does not violate the proportional hazard assumptions at the significance level of 0.05, and the lines 
in Figure 3 seems flat.   
 
Table 2 Cox Proportional Hazard Model for Death Following Breast Cancer Recurrence 
Type 1  
Model: Cox Proportional Hazard Model  
  coefficient SE (coefficient) Z p-value 
Nodal Status 1 0.56 0.07 7.70 <0.0001 
Age  -0.10 0.32 -0.33 0.74 
Tumor Size   0.82 0.14 6.00 <0.0001 
 
 
Table 3 Test of Proportional Hazard in Model for Death following Breast Cancer Recurrence 
Type 1  
Check proportional Hazard Assumption  
  rho chisq p-value 
Nodal Status 1 -0.10 8.22 4.14*10-3 
Age  0.23 44.15 <0.0001 
Tumor Size   -0.09 3.52 6.06*10-2 
Global  NA 62.30 <0.0001 
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Figure 2 Schonefeld Residual Plot for Model of Death following Breast Cancer Recurrence 
 
Table 4 Cox Proportional Hazard Model for Death Not Related To Breast Cancer 
Type 2 
Model: Cox Proportional Hazard Model  
  coefficient SE (coefficient) Z p-value 
Nodal Status 1 0.06 0.1 0.58 0.57 
Age  6.73 0.46 14.56 <0.0001 
Tumor Size   0.29 0.23 1.25 0.21 
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Table 5 Test of Proportional Hazard in Model for Death Not Related To Breast Cancer 
Type 2  
Check proportional Hazard Assumption  
  rho chisq p-value 
Nodal Status 1 -0.05 1.03 0.31 
Age  0.04 1.04 0.31 
Tumor Size   -0.02 0.23 0.63 
Global  NA 2.52 0.47 
 
 
Figure 3 Schonefeld Residual Plot for Model of Death not Related To Breast Cancer 
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Second, we assessed the effects of covariates on the cumulative incidence function by 
formulating generalized linear model with GEE based on pseudo-observations. First, we chose the 
different time points. The strategy for us to choose the time points is the same as how Andersen 
and Klein did. The strategy is that we made sure that the number of events would be evenly 
distributed across time intervals. 
 To examine whether the number of time points and the link function influence the effect 
of covariate estimation, we varied the number of time points (12, 6 and 4), and used two different 
link functions (logit link and complementary log-log link functions).  
Table 6 shows that results of the method for death following breast cancer recurrence based 
on 12, 6 and 4 time points and the independence working covariance models under both link 
functions. The number of the time points and link function does not influence the relationship 
between covariates and the outcome. According to the p-values of table 6, there is association 
between nodal status, tumor size, age and cumulative incidence. In the models with 
complementary log-log link, the positive value of mean (β) for the covariates represents higher 
cumulative incidence following breast cancer recurrence for patients. As we expected, prognosis 
depends on tumor size and nodal status; larger tumor size and positive nodal status cause the worse 
prognosis. Furthermore, younger women at diagnosis are more likely to get aggressive tumors and 
have a higher chance to recur both in locoregional tumor and distant sites [5]. All the models with 
complementary log-log link reflect the relationship between the cumulative incidence and 
covariates. The patients with positive nodal status have higher a chance of death following breast 
cancer recurrence compared to the patients with negative nodal status; the patients with larger 
tumor size have a higher chance of breast cancer-related death, and the younger patients have a 
higher chance of breast cancer-related death. The models with logistic link show similar results. 
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The interpretation of the models with the logistic link is different with the model with 
complementary log-log link. We interpret exp(β) as the odds ratio between the current category 
and baseline category. For example, with 12 time points the odds of positive nodal status is 2.08 
times the odds of the negative nodal status, after holding the other covariates constant. There is a 
1.5% increase in the odds of breast cancer-related death for one-unit increase in tumor size while 
a 1.7% decrease in the odds of breast cancer-related death for one-unit increase in age.  In 
summary, the patients with positive nodal status, larger tumor size and younger in age have higher 
odds of breast cancer-related death.  
 
Table 6 Complementary Log-Log Model and Logistic Model for Breast Cancer-Related Death 
Type1  
Time Points = 12  
 Link Function = complementary log-log    Link Function = logistic  
Variables   mean SD  Z p-value   mean SD  Z p-value  
Time Points 1.14 -2.96 0.23 
-
12.88 <0.0001  -3.01 0.28 -10.64 <0.0001 
 2.02 -2.08 0.21 -9.83 <0.0001  -2.06 0.27 -7.75 <0.0001 
 2.87 -1.66 0.21 -8.05 <0.0001  -1.59 0.26 -6.09 <0.0001 
 3.91 -1.36 0.21 -6.62 <0.0001  -1.25 0.26 -4.78 <0.0001 
 5.1 -1.14 0.2 -5.6 <0.0001  -1 0.26 -3.82 0.0001 
 6.5 -0.97 0.2 -4.77 <0.0001  -0.78 0.26 -2.99 0.003 
 7.93 -0.8 0.2 -3.96 0.0001  -0.57 0.26 -2.19 0.03 
 9.96 -0.67 0.2 -3.32 0.0009  -0.4 0.26 -1.56 0.12 
 12.51 -0.56 0.2 -2.8 0.005  -0.26 0.26 -1.01 0.31 
 15.66 -0.45 0.2 -2.27 0.02  -0.12 0.26 -0.46 0.64 
 19.68 -0.36 0.2 -1.8 0.07  0.01 0.26 0.04 0.97 
 24.84 -0.27 0.2 -1.35 0.18  0.14 0.26 0.53 0.6 
Nodal Status 1 0.58 0.08 7.54 <0.0001  0.73 0.1 7.38 <0.0001 
Tumor Size   0.01 0.002 5.71 <0.0001  0.015 0.003 5.73 <0.0001 
Age   -0.01 0.003 -4.1 <0.0001  -0.017 0.004 -4.07 <0.0001 
           
Time Points = 6 
 Link Function = complementary log-log  Link Function = logistic  
Variables   Mean  SD Z p-value  Mean SD Z p-value 
Time Points 2.02 -2.09 0.21 -9.91 <0.0001  -2.07 0.27 -7.78 <0.0001 
 3.91 -1.37 0.2 -6.69 <0.0001  -1.26 0.26 -4.82 <0.0001 
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Table 6 Continued 
 6.5 -0.98 0.2 -4.85 <0.0001  -0.79 0.26 -3.04 0.002 
 9.96 -0.68 0.2 -3.39 0.0007  -0.41 0.26 -1.61 0.11 
 15.66 -0.47 0.2 -2.35 0.019  -0.13 0.26 -0.52 0.6 
 24.84 -0.28 0.2 -1.42 0.15  0.12 0.26 0.47 0.64 
Nodal Status 1 0.56 0.08 7.43 <0.0001  0.72 0.1 7.28 <0.0001 
Tumor Size   0.01 0.002 5.72 <0.0001  0.01 0.003 5.72 <0.0001 
Age   -0.01 0.003 -4 0.0001  -0.02 0.004 -3.99 0.0001 
           
Time Points = 4 
 Link Function = complementary log-log  Link Function = logistic  
Variables   Mean SD  Z p-value   Mean  SD  Z  p-value 
Time Points 2.87 -1.68 0.2 -8.24 <0.0001  -1.63 0.26 -6.21 <0.0001 
 6.5 -0.99 0.2 -4.96 <0.0001  -0.82 0.26 -3.15 0.002 
 12.5 -0.59 0.2 -2.97 0.003  -0.31 0.26 -1.19 0.23 
 24.84 -0.3 0.2 -1.53 0.1  0.09 0.26 0.34 0.73 
Nodal Status  1 0.55 0.08 7.26 <0.0001  0.71 0.1 7.12 <0.0001 
Tumor Size   0.01 0.002 5.55 <0.0001  0.91 0.003 5.6 <0.0001 
Age   -0.01 0.003 -3.84 0.0001  -0.02 0.004 -3.81 0.0001 
 
Table 7 shows that the results for death not related to breast cancer with 12, 6 and 4 time 
points and independence working covariance. The results show that the result of the regression 
model does not change when the number of time points are 12 or 6. However, nodal status is 
marginally significant in the model with complementary log-log link function and the model with 
logistic link function when the number of time points is equal to 4. Because the number of the 
parameters we estimated in the models with 4 time points is less than the number of the parameters 
we estimated in the models with 12 or 6 time points, the degrees of freedom increase. So, the p-
values of the models with 4 time points are smaller than that of the model with 12 or 6 time points. 
The models with the complementary log-log link function and ones with logistic link function 
show that the nodal status and tumor size are associated with death unrelated to breast cancer. Age 
is significantly associated with the death not due to breast cancer. Although the tumor size and 
nodal status are related to death following breast cancer recurrence, they are not significantly 
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related to death not due to breast cancer. The results of the regression analysis for death not due to 
breast cancer with complementary log-log link function shows that the older patients have higher 
chance of death. The result of the regression analysis for death not due to breast cancer with the 
logistic link function shows that the older patients have higher odds of death not due to breast 
cancer compared to the younger patients.  
 
Table 7 Complementary Log-Log Model and Logistic Model for Death Not Related to Breast Cancer 
Type2 
Time Points = 12  
 Link Function = complementary log-log    Link Function = logistic  
Variables   Mean SD  Z p-value   Mean SD  Z p-value  
Time Points 1.14 -7.86 0.42 -18.72 <0.0001  -8.72 0.5 -17.28 <0.0001 
 2.02 -7.67 0.4 -18.97 <0.0001  -8.52 0.49 -17.42 0 
 2.87 -7.26 0.39 -18.62 <0.0001  -8.09 0.47 -17.03 0 
 3.91 -6.77 0.36 -18.56 <0.0001  -7.55 0.45 -16.89 0 
 5.1 -6.48 0.37 -17.64 <0.0001  -7.25 0.45 -16.12 0 
 6.5 -6.19 0.36 -17.01 <0.0001  -6.92 0.44 -15.58 0 
 7.93 -5.94 0.36 -16.5 <0.0001  -6.64 0.44 -15.14 0 
 9.96 -5.68 0.36 -15.8 <0.0001  -6.34 0.44 -14.54 0 
 12.51 -5.44 0.36 -15.08 <0.0001  -6.07 0.44 -13.91 0 
 15.66 -5.2 0.36 -14.46 <0.0001  -5.79 0.43 -13.33 0 
 19.68 -4.93 0.36 -13.72 <0.0001  -5.46 0.43 -12.65 0 
 24.84 -4.67 0.36 -13.09 <0.0001  -5.13 0.43 -12 0 
Nodal Status 1 -0.13 0.11 -1.11 0.27  -0.16 0.14 -1.16 0.25 
Tumor Size   -0.003 0.003 -0.95 0.34  -0.003 0.004 -0.71 0.48 
Age   0.07 0.005 12.57 <0.0001  0.08 0.006 12.05 0 
           
Time Points = 6 
 Link Function = complementary log-log  Link Function = logistic 
Variables   Mean  SD Z p-value  Mean SD Z p-value 
Time Points 2.02 -7.51 0.39 -19.04 <0.0001  -8.38 0.48 -17.48 <0.0001 
 3.91 -6.62 0.35 -18.66 <0.0001  -7.43 0.44 -16.96 <0.0001 
 6.5 -6.03 0.35 -17.13 <0.0001  -6.79 0.43 -15.67 <0.0001 
 9.96 -5.52 0.35 -15.89 <0.0001  -6.22 0.43 -14.61 <0.0001 
 15.66 -5.04 0.35 -14.52 <0.0001  -5.67 0.43 -13.4 <0.0001 
 24.84 -4.52 0.35 -13.07 <0.0001  -5.01 0.43 -12 <0.0001 
Nodal Status 1 -0.17 0.11 -1.53 0.13  -0.21 0.14 -1.56 0.12 
Tumor Size   -0.003 0.003 -1.02 0.31  -0.003 0.004 -0.79 0.43 
Age   0.06 0.005 12.53 <0.0001  0.08 0.006 12.05 <0.0001 
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Table 7 Continued 
Time Points = 4 
 Link Function = complementary log-log  Link Function = logistic 
Variables   Mean SD  Z p-value   Mean  SD  Z  p-value 
Time Points 2.87 -6.87 0.36 -18.86 <0.0001  -7.69 0.45 -17.16 <0.0001 
 6.5 -5.8 0.34 -17.18 <0.0001  -6.54 0.42 -15.66 <0.0001 
 12.5 -5.05 0.33 -15.17 <0.0001  -5.69 0.41 -13.94 <0.0001 
 24.84 -4.3 0.33 -12.99 <0.0001  -4.77 0.4 -11.89 <0.0001 
Nodal Status  1 -0.21 0.11 -1.94 0.05  -0.26 0.13 -1.99 0.047 
Tumor Size   -0.004 0.003 -1.22 0.22  -0.003 0.004 -0.98 0.33 
Age   0.06 0.005 12.41 <0.0001  0.07 0.006 11.94 <0.0001 
 
Comparing the Cox proportional hazards model and generalized linear model with GEE 
based on the pseudo-observations, all models for breast cancer-related death show that nodal status 
and tumor size had significant effects. However, the effect of age was different between Cox model 
and generalized linear model with GEE. All models for death not due to breast cancer show that 
the effect of nodal status, tumor size and age are the same.     
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4.0 Discussion 
The pseudo observation method makes regression modeling for censored survival data 
more flexible, allowing for different link functions [11]. Compared to the Cox model for cause-
specific hazard analysis, the generalized linear model with GEE based on pseudo observations 
does not require strict assumption such as the proportional hazards assumption. Because the 
method replaces the censoring and complete data with the pseudo values, one can use the standard 
generalized linear model to estimate the parameters and evaluate the relationship between 
covariates and cumulative incidence directly.  
In this thesis, we used the independent working covariance structure. Klein and Andersen 
(2007) conducted a Monte Carlo study to assess whether different working covariances affect the 
estimation in GEE procedure [1]. They compared independent working covariance, exact working 
covariance and empirical working covariance and used five time points. The result showed that 
there was no significant difference in parameter estimates using different working covariance 
structure. Based on their results, we chose the independent working covariance which is the 
simplest working covariance structure. The results of B-04 study show that the different number 
of time points does not influence the estimates from the GEE procedure. Klein and Anderson 
(2007) also performed the Monte Carlo simulation, and the result showed that number of time 
points does not have influence on the model fit [1]. 
The results of the B-04 study seem to show that the link function does not influence the 
effects of covariates on cumulative incidence function. The standard deviations of covariates in 
the logistic link function model is larger than ones from the complementary log-log link function 
model.   
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Although the result of the B-04 study shows the link function does not effects of covariates, 
the choice link function introduces different model assumptions in general. According to Monte 
Carlo study, the different number of time points do not affect the effect of the covariates on 
cumulative incidence. However, Andersen and Klein suggested that 5 to 10 time points would be 
sufficient to provide reasonable estimates. 
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Appendix A R code  
B-04 Study 
R code for cause-specific Cox model  
b04<-read.table("C:\\Users\\cszhe\\OneDrive\\Documents\\thesis\\pseudo  
observation\\b04.with.covariates.csv",sep=",",header = T) 
b04$age <- b04$age*100 
b04$tsize <- b04$tsize*100 
 
library(survival) 
library(cmprsk) 
library(ggplot2) 
library(zoo) 
library(survminer) 
 
#summary of event status and nodal status 
table(b04$event.status) 
table(b04$nodal.status) 
 
# draw cumulative incidence curve 
b04$nodal.status[b04$nodal.status==0]="negative" 
b04$nodal.status[b04$nodal.status==1]="positive" 
cif1 <- cuminc(ftime = b04$time,fstatus = b04$event.status) 
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plot(cif1,col=1:2,xlab = "Year", main = "CIC of type1 and type2 event",wh=c(0,5)) 
legend("topleft",c("death with breast cancer recurring","death not due to breast cancer"),  
lty=c(1,2), col=c(1,2)) 
# cox model for type1 event  
coxfit1 <- coxph(Surv(time,event.status==1)~nodal.status+age+tsize,data=b04) 
summary(coxfit1) 
 
# proportional hazard assumption check for type1  
test.ph1 <- cox.zph(coxfit1) 
test.ph1 
ggcoxzph(test.ph1) 
 
# cox model for type 2 event  
coxfit2 <- coxph(Surv(time,event.status==2)~nodal.status+age+tsize,data=b04) 
summary(coxfit2) 
 
# proportional hazard assumption check for type2  
test.ph2 <- cox.zph(coxfit2) 
test.ph2 
ggcoxzph(test.ph2) 
 
R code for generalized linear model with GEE based on pseudo-observations 
library(KMsurv) 
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library(geepack) 
library(pseudo) 
library(MuMIn) 
 
b04<-read.table("C:\\Users\\cszhe\\OneDrive\\Documents\\thesis\\pseudo 
observation\\b04.with.covariates.csv",sep=",",header = T) 
 
 
# choose the cut off points  
sum(as.numeric(b04$event.status!=0)) 
b04.event=subset(b04,b04$event.status!=0) 
b04.event=b04.event[order(b04.event$time),] 
cutoff1=b04.event[c(100,200,300,400,500,600,700,800,900,1000,1100,1200),]$time 
cutoff2=b04.event[c(200,400,600,800,1000,1200),]$time 
cutoff3=b04.event[c(300,600,900,1200),]$time 
 
 
# multiply 100 into age and tsize 
b04$age <- b04$age*100 
b04$tsize <- b04$tsize*100 
 
# relapse  
# cutoff1  
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# generate pseudo observations  
pseudo <- pseudoci(time=b04$time,event=b04$event.status,tmax=cutoff1) 
 
 
# rearrange the data into a long data set, use only pseudo-observations for type2 
b <- NULL 
for(it in 1:length(pseudo$time)){ 
  b <- rbind(b,cbind(b04,pseudo = pseudo$pseudo[[2]][,it], 
                      tpseudo = pseudo$time[it],id=1:nrow(b04))) 
} 
b <- b[order(b$id),] 
 
 
# fit the model- cloglog1 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
              age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "cloglog", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.cloglog1 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
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                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.cloglog1 
 
 
#fit the model - logit1  
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "logit", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.logit1 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                   Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                   PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.logit1 
 
 
 
 
# cutoff2 
# generate pseudo observations  
pseudo <- pseudoci(time=b04$time,event=b04$event.status,tmax=cutoff2) 
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# rearrange the data into a long data set, use only pseudo-observations for type2 
b <- NULL 
for(it in 1:length(pseudo$time)){ 
  b <- rbind(b,cbind(b04,pseudo = pseudo$pseudo[[2]][,it], 
                     tpseudo = pseudo$time[it],id=1:nrow(b04))) 
} 
b <- b[order(b$id),] 
 
 
# fit the model-cloglog2 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "cloglog", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.cloglog2 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.cloglog2 
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# fit the model-logit2 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "logit", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.logit2 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.logit2 
 
# cutoff3 
# generate pseudo observations  
pseudo <- pseudoci(time=b04$time,event=b04$event.status,tmax=cutoff3) 
 
 
# rearrange the data into a long data set, use only pseudo-observations for type2 
b <- NULL 
for(it in 1:length(pseudo$time)){ 
  b <- rbind(b,cbind(b04,pseudo = pseudo$pseudo[[2]][,it], 
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                     tpseudo = pseudo$time[it],id=1:nrow(b04))) 
} 
b <- b[order(b$id),] 
 
 
# fit the model - cloglog3 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "cloglog", corstr="independence") 
#The results using the AJ variance estimate 
fit.cloglog3 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.cloglog3 
 
# fit the model - logit3 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "logit", corstr="independence") 
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#The results using the AJ variance estimate 
fit.logit3 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                   Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                   PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.logit3 
 
# death  
# cutoff1  
# generate pseudo observations  
pseudo <- pseudoci(time=b04$time,event=b04$event.status,tmax=cutoff1) 
 
# rearrange the data into a long data set, use only pseudo-observations for type2 
b <- NULL 
for(it in 1:length(pseudo$time)){ 
  b <- rbind(b,cbind(b04,pseudo = pseudo$pseudo[[1]][,it], 
                     tpseudo = pseudo$time[it],id=1:nrow(b04))) 
} 
b <- b[order(b$id),] 
 
 
# fit the model- cloglog1 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
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               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "cloglog", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.cloglog1 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.cloglog1 
 
 
#fit the model - logit1  
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "logit", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.logit1 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                   Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                   PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.logit1 
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# cutoff2 
# generate pseudo observations  
pseudo <- pseudoci(time=b04$time,event=b04$event.status,tmax=cutoff2) 
 
# rearrange the data into a long data set, use only pseudo-observations for type2 
b <- NULL 
for(it in 1:length(pseudo$time)){ 
  b <- rbind(b,cbind(b04,pseudo = pseudo$pseudo[[1]][,it], 
                     tpseudo = pseudo$time[it],id=1:nrow(b04))) 
} 
b <- b[order(b$id),] 
 
 
# fit the model-cloglog2 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "cloglog", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.cloglog2 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
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                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.cloglog2 
 
 
# fit the model-logit2 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "logit", corstr="independence") 
 
 
#The results using the AJ variance estimate 
fit.logit2 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                   Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                   PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.logit2 
 
# cutoff3 
# generate pseudo observations  
pseudo <- pseudoci(time=b04$time,event=b04$event.status,tmax=cutoff3) 
# rearrange the data into a long data set, use only pseudo-observations for type2 
b <- NULL 
for(it in 1:length(pseudo$time)){ 
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  b <- rbind(b,cbind(b04,pseudo = pseudo$pseudo[[1]][,it], 
                     tpseudo = pseudo$time[it],id=1:nrow(b04))) 
} 
b <- b[order(b$id),] 
 
 
 
# fit the model - cloglog3 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
             mean.link = "cloglog", corstr="independence") 
 
#The results using the AJ variance estimate 
fit.cloglog3 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                     Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                     PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.cloglog3 
 
# fit the model - logit3 
library(geepack) 
fit <- geese(pseudo ~ as.factor(tpseudo) + as.factor(b$nodal.status) + tsize + 
               age -1, data =b, id=id, jack = TRUE, scale.fix=TRUE, family=gaussian, 
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             mean.link = "logit", corstr="independence") 
 
#The results using the AJ variance estimate 
fit.logit3 = cbind(mean = round(fit$beta,4), SD = round(sqrt(diag(fit$vbeta.ajs)),4), 
                   Z = round(fit$beta/sqrt(diag(fit$vbeta.ajs)),4), 
                   PVal = round(2-2*pnorm(abs(fit$beta/sqrt(diag(fit$vbeta.ajs)))),4)) 
fit.logit3 
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